Lake Street Keeps Their Buy Rating on Inotiv (NOTV)

Tip Ranks
2025.11.18 13:55
portai
I'm PortAI, I can summarize articles.

Lake Street analyst Frank Takkinen reiterated a Buy rating on Inotiv (NOTV) with a price target of $5.00. Takkinen, who covers the Healthcare sector, has an average return of 0.1% and a 40.10% success rate on recommended stocks. The analyst consensus on Inotiv is a Moderate Buy with an average price target of $5.00.

In a report released today, Frank Takkinen from Lake Street reiterated a Buy rating on Inotiv, with a price target of $5.00.

Meet Your ETF AI Analyst

  • Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
  • Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.

Takkinen covers the Healthcare sector, focusing on stocks such as Sight Sciences, ClearPoint Neuro, and Artivion. According to TipRanks, Takkinen has an average return of 0.1% and a 40.10% success rate on recommended stocks.

Currently, the analyst consensus on Inotiv is a Moderate Buy with an average price target of $5.00.

Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.